These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10838557)

  • 1. Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass.
    Pagni S; Austin EH
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1297-8. PubMed ID: 10838557
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis.
    Grayling M; Deakin CD
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):426-7. PubMed ID: 12579121
    [No Abstract]   [Full Text] [Related]  

  • 3. Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?
    Evora PR
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):632-4. PubMed ID: 10694631
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin.
    Del Duca D; Sheth SS; Clarke AE; Lachapelle KJ; Ergina PL
    Ann Thorac Surg; 2009 Feb; 87(2):640-2. PubMed ID: 19161806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of methylene blue in the treatment of vasoplegic syndrome after heart surgery: other perspectives on the case].
    Egea-Guerrero JJ; Martín-Bermúdez R; Miralles-Aguiar F; Revuelto-Rey J
    Med Intensiva; 2007 Dec; 31(9):528; author reply 529. PubMed ID: 18039456
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery.
    Yiu P; Robin J; Pattison CW
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):195-6. PubMed ID: 10384205
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasoplegic syndrome--the role of methylene blue.
    Shanmugam G
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene blue for refractory hypotension: a case report.
    Weissgerber AJ
    AANA J; 2008 Aug; 76(4):271-4. PubMed ID: 18777811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
    Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
    Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of methylene blue in the treatment of vasoplegic syndrome of post-operative heart surgery].
    Mora-Ordóñez JM; Sánchez-Llorente F; Galeas-López JL; Hernández Sierra B; Prieto-Palomino MA; Vera-Almazán A
    Med Intensiva; 2006; 30(6):293-6. PubMed ID: 16949005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis.
    Taylor K; Holtby H
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):566. PubMed ID: 16077431
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
    Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
    Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
    Carley M; Schaff J; Lai T; Poppers J
    A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methylene blue on refractory neonatal hypotension.
    Driscoll W; Thurin S; Carrion V; Steinhorn RH; Morin FC
    J Pediatr; 1996 Dec; 129(6):904-8. PubMed ID: 8969734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylene blue in the therapy of vasoplegic syndrome after cardiac surgery procedure].
    Ríha H; Ríhová L; Pind'ák M; Brezina A; Pirk J
    Cas Lek Cesk; 2006; 145(4):322-4. PubMed ID: 16639934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass.
    Maslow AD; Stearns G; Butala P; Schwartz CS; Gough J; Singh AK
    Anesth Analg; 2006 Jul; 103(1):2-8, table of contents. PubMed ID: 16790616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue.
    Sparicio D; Landoni G; Zangrillo A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):608. PubMed ID: 14762391
    [No Abstract]   [Full Text] [Related]  

  • 19. Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery.
    Dagenais F; Mathieu P
    Can J Cardiol; 2003 Feb; 19(2):167-9. PubMed ID: 12601442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene blue, midodrine, and pseudoephedrine: a review of alternative agents for refractory hypotension in the intensive care unit.
    Van Berkel MA; Fuller LA; Alexandrov AW; Jones GM
    Crit Care Nurs Q; 2015; 38(4):345-58. PubMed ID: 26335214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.